CJC-1295 (without DAC) is a synthetic peptide analog of growth hormone–releasing hormone (GHRH) designed for use in controlled laboratory studies.
This variant without DAC (Drug Affinity Complex) features a shorter half-life, allowing researchers to observe pulsatile growth hormone release patterns and short-term peptide kinetics in in-vitro or biochemical environments.
Theramedix CJC-1295 (w/o DAC) is produced to the same strict purity and sterility standards as all peptides in the Theramedix performance line.

This compound is supplied strictly for research use only and is not for human or veterinary administration.